Jackson Creek Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Jackson Creek Investment Advisors's REGN Position: Q2 2026 in Review
Jackson Creek Investment Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 748 shares — an estimated $578K sold.
Jackson Creek Investment Advisors first reported a position in REGN in Q3 2020 and held it in 20 quarters. The position peaked at $1.23M in Q1 2023. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Jackson Creek Investment Advisors reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Jackson Creek Investment Advisors sold 748 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $578K.
- Jackson Creek Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2020 and held it in 20 quarters.
- Jackson Creek Investment Advisors's Regeneron Pharmaceuticals position peaked at $1.23M in Q1 2023.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.